These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19911951)

  • 1. Criterion for excipients screening in the development of nanoemulsion formulation of three anti-inflammatory drugs.
    Shakeel F
    Pharm Dev Technol; 2010; 15(2):131-8. PubMed ID: 19911951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
    Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
    Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
    Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
    Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.
    Dasgupta S; Dey S; Choudhury S; Mazumder B
    Expert Opin Drug Deliv; 2013 Apr; 10(4):411-20. PubMed ID: 23316798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation.
    Song WH; Park JH; Yeom DW; Ahn BK; Lee KM; Lee SG; Woo HS; Choi YW
    Arch Pharm Res; 2013 Jan; 36(1):69-78. PubMed ID: 23325487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
    Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method.
    Kumar A; Jain SK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):515-521. PubMed ID: 27007745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
    Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
    AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population.
    Pathak D; Dahiya S; Pathak K
    Acta Pharm; 2008 Mar; 58(1):99-110. PubMed ID: 18337211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical delivery of celecoxib using microemulsion.
    Subramanian N; Ghosal SK; Moulik SP
    Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoprofen-loaded pomegranate seed oil nanoemulsion stabilized by pullulan: Selective antiglioma formulation for intravenous administration.
    Ferreira LM; Cervi VF; Gehrcke M; da Silveira EF; Azambuja JH; Braganhol E; Sari MH; Zborowski VA; Nogueira CW; Cruz L
    Colloids Surf B Biointerfaces; 2015 Jun; 130():272-7. PubMed ID: 25935266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Labrasol on self-nanoemulsification efficiency of ramipril nanoemulsion.
    Shafiq S; Shakeel F
    Pharmazie; 2009 Dec; 64(12):812-7. PubMed ID: 20095139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.